AIM ImmunoTech Secures New State-of-the-Art Facility for Product Development and Testing

2 years ago

Company enters into a lease agreement with the state-supported New Jersey Bioscience Center at North Brunswick, one of the nation’s…

Acer Therapeutics Announces Promotion of Tanya Hayden to Chief Operating Officer

2 years ago

NEWTON, Mass., June 21, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition,…

CareView Communications Selected to Exhibit Patient Safety System at Vizient Innovative Technology Exchange

2 years ago

LEWISVILLE, Texas--(BUSINESS WIRE)--CareView Communications, Inc. ("CareView" or the "Company") (OTCQB: CRVW), an information technology provider to the healthcare industry, has…

Imperative Care Appoints Henrietta Fore and Stacy Enxing Seng to Board of Directors

2 years ago

Respected leaders bring deep industry expertise and diverse perspectives to further enable company’s substantial growth CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc.…

Agilent Laboratory Achieves Green Lab Certification

2 years ago

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company’s customer demonstration laboratory in Waldbronn, Germany has…

More Than 80% of Healthcare Executives Expect the Metaverse Will Have a Positive Impact on Their Organizations, According to a New Accenture Report

2 years ago

Emerging technologies are converging to reshape digital healthcare NEW YORK--(BUSINESS WIRE)--Accenture’s (NYSE: ACN) Digital Health Technology Vision 2022 report found…

Barnes Announces Appointment of Thomas J. Hook as President and Chief Executive Officer; CEO Patrick Dempsey to Become Executive Vice Chairman of Barnes

2 years ago

Board Names Medical Technology CEO and Barnes Director as Company’s New Leader After Dempsey’s Nearly 10 Years as Barnes’ CEO…

Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma

2 years ago

Orphan Designation Granted by EMA to MTX110 Development for the Treatment of GliomaABINGDON, NR / ACCESSWIRE / June 21, 2022…

NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer

2 years ago

FT. MYERS, FL / ACCESSWIRE / June 21, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing…

Midatech Pharma PLC Announces Directorate Change

2 years ago

ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 20, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving…